- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 820827, 9 pages
Fibronectin Binding Is Required for Acquisition of Mesenchymal/Endothelial Differentiation Potential in Human Circulating Monocytes
1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
2Innovative Drug Research Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd., 3 Miyahara, Takasaki, Gunma 370-1295, Japan
3Department of Biology, School of Education, Waseda University, 2-2 Wakamatsu, Shinjuku-ku, Tokyo 162-8480, Japan
Received 4 July 2012; Accepted 24 September 2012
Academic Editor: Jacek Tabarkiewicz
Copyright © 2012 Noriyuki Seta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- S. Gordon and P. R. Taylor, “Monocyte and macrophage heterogeneity,” Nature Reviews Immunology, vol. 5, no. 12, pp. 953–964, 2005.
- R. Bucala, L. A. Spiegel, J. Chesney, M. Hogan, and A. Cerami, “Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair,” Molecular Medicine, vol. 1, no. 1, pp. 71–81, 1994.
- Y. Zhao, D. Glesne, and E. Huberman, “A human peripheral blood monocyte-derived subset acts as pluripotent stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 5, pp. 2426–2431, 2003.
- P. Romagnani, F. Annunziato, F. Liotta et al., “CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors,” Circulation Research, vol. 97, no. 4, pp. 314–322, 2005.
- B. Dresske, N. E. El Mokhtari, H. Ungefroren et al., “Multipotent cells of monocytic origin improve damaged heart function,” American Journal of Transplantation, vol. 6, no. 5, part I, pp. 947–958, 2006.
- N. Seta and M. Kuwana, “Derivation of multipotent progenitors from human circulating CD14+ monocytes,” Experimental Hematology, vol. 38, no. 7, pp. 557–563, 2010.
- M. Kuwana, Y. Okazaki, H. Kodama et al., “Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation,” Journal of Leukocyte Biology, vol. 74, no. 5, pp. 833–845, 2003.
- H. Kodama, T. Inoue, R. Watanabe et al., “Cardiomyogenic potential of mesenchymal progenitors derived from human circulating CD14+ monocytes,” Stem Cells and Development, vol. 14, no. 6, pp. 676–686, 2005.
- H. Kodama, T. Inoue, R. Watanabe et al., “Neurogenic potential of progenitors derived from human circulating CD14+ monocytes,” Immunology and Cell Biology, vol. 84, no. 2, pp. 209–217, 2006.
- M. Kuwana, Y. Okazaki, H. Kodama, T. Satoh, Y. Kawakami, and Y. Ikeda, “Endothelial differentiation potential of human monocyte-derived multipotential cells,” Stem Cells, vol. 24, no. 12, pp. 2733–2743, 2006.
- S. Bennett, S. B. Por, E. R. Stanley, and S. N. Breit, “Monocyte proliferation in a cytokine-free, serum-free system,” Journal of Immunological Methods, vol. 153, no. 1-2, pp. 201–212, 1992.
- S. T. Moss and J. A. Hamilton, “Proliferation of a subpopulation of human peripheral blood monocytes in the presence of colony stimulating factors may contribute to the inflammatory process in diseases such as rheumatoid arthritis,” Immunobiology, vol. 202, no. 1, pp. 18–25, 2000.
- S. S. Jacob, P. Shastry, and P. R. Sudhakaran, “Monocyte-macrophage differentiation in vitro: modulation by extracellular matrix protein substratum,” Molecular and Cellular Biochemistry, vol. 233, no. 1-2, pp. 9–17, 2002.
- S. Stenman and A. Vaheri, “Distribution of a major connective tissue protein, fibronectin, in normal human tissues,” Journal of Experimental Medicine, vol. 147, no. 4, pp. 1054–1064, 1978.
- A. R. De Fougerolles and V. E. Koteliansky, “Regulation of monocyte gene expression by the extracellular matrix and its functional implications,” Immunological Reviews, vol. 186, pp. 208–220, 2002.
- F. G. Giancotti, “Integrin signaling: specificity and control of cell survival and cell cycle progression,” Current Opinion in Cell Biology, vol. 9, no. 5, pp. 691–700, 1997.
- C. Shi and D. I. Simon, “Integrin signals, transcription factors, and monocyte differentiation,” Trends in Cardiovascular Medicine, vol. 16, no. 5, pp. 146–152, 2006.
- K. Kumano and M. Kurokawa, “The role of Runx1/AML1 and Evi-1 in the regulation of hematopoietic stem cells,” Journal of Cellular Physiology, vol. 222, no. 2, pp. 282–285, 2010.
- K. Iwatsuki, K. Tanaka, T. Kaneko et al., “Runx1 promotes angiogenesis by downregulation of insulin-like growth factor-binding protein-3,” Oncogene, vol. 24, no. 7, pp. 1129–1137, 2005.
- J. R. A. J. Moonen, G. Krenning, M. G. L. Brinker, J. A. Koerts, M. J. A. Van Luyn, and M. C. Harmsen, “Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny,” Cardiovascular Research, vol. 86, no. 3, pp. 506–515, 2010.
- M. Wu, D. S. Melichian, M. De La Garza et al., “Essential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healing,” American Journal of Pathology, vol. 175, no. 3, pp. 1041–1055, 2009.
- B. H. Luo, C. V. Carman, and T. A. Springer, “Structural basis of integrin regulation and signaling,” Annual Review of Immunology, vol. 25, pp. 619–647, 2007.
- C. Weber, R. Alon, B. Moser, and T. A. Springer, “Sequential regulation of α4β1 and α5β1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis,” Journal of Cell Biology, vol. 134, no. 4, pp. 1063–1073, 1996.
- K. Feghali and D. Grenier, “Priming effect of fibronectin fragments on the macrophage inflammatory response: potential contribution to periodontitis,” Inflammation, vol. 35, no. 5, pp. 1696–1705, 2012.
- D. H. Beezhold and C. Personius, “Fibronectin fragments stimulate tumor necrosis factor secretion by human monocytes,” Journal of Leukocyte Biology, vol. 51, no. 1, pp. 59–64, 1992.